Literature DB >> 28706909

Volumetric assessment in malignant pleural mesothelioma.

David J Murphy1, Ritu R Gill1.   

Abstract

Malignant pleural mesothelioma (MPM) is a highly malignant pleural neoplasm with a dismal prognosis. Multimodality approach including surgery and chemotherapy are utilized to treat patients with resectable disease. Clinical staging allows for selection of patients for treatment strategies, but has not been found to be prognostic and is plagued by high interobserver variability. Tumor volume measurement on cross-sectional imaging has emerged as a potential quantitative tool with prognostic significance. This review focuses on volumetric assessment from cross-sectional imaging (CT, MRI, 18F-FDG PET/CT) and the potential prognostic benefit and applications.

Entities:  

Keywords:  CT; Mesothelioma; malignant pleural mesothelioma (MPM); volume; volumetric CT

Year:  2017        PMID： 28706909      PMCID： PMC5497118          DOI： 10.21037/atm.2017.05.23

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


  47 in total

1.  Volumetry: an alternative to assess therapy response for malignant pleural mesothelioma?

Authors:  T Frauenfelder; M Tutic; W Weder; R P Götti; R A Stahel; B Seifert; I Opitz
Journal:  Eur Respir J       Date:  2011-01-27       Impact factor: 16.671

2.  Do Radiologists Have Stage Fright? Tumor Staging and How We Can Add Value to the Care of Patients with Cancer.

Authors:  Christine M Glastonbury; Priya R Bhosale; Peter L Choyke; Carl J D'Orsi; Jeremy J Erasmus; Ritu R Gill; Suresh K Mukherji; David M Panicek; Lawrence H Schwartz; Rathan M Subramaniam; Daniel C Sullivan
Journal:  Radiology       Date:  2016-01       Impact factor: 11.105

3.  Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: stratification of survival with CT-derived tumor volume.

Authors:  Ritu R Gill; William G Richards; Beow Y Yeap; Shin Matsuoka; Andrea S Wolf; Victor H Gerbaudo; Raphael Bueno; David J Sugarbaker; Hiroto Hatabu
Journal:  AJR Am J Roentgenol       Date:  2012-02       Impact factor: 3.959

4.  Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staging implications.

Authors:  Jeremy J Erasmus; Mylene T Truong; W Roy Smythe; Reginald F Munden; Edith M Marom; David C Rice; Ara A Vaporciyan; Garrett L Walsh; Bradley S Sabloff; Lyle D Broemeling; Craig W Stevens; Katherine M Pisters; Donald A Podoloff; Homer A Macapinlac
Journal:  J Thorac Cardiovasc Surg       Date:  2005-06       Impact factor: 5.209

5.  Survival and prognostic factors in malignant pleural mesothelioma: a retrospective study of 314 patients in the west part of Japan.

Authors:  Shuko Nojiri; Kenichi Gemba; Keisuke Aoe; Katsuya Kato; Takuhiro Yamaguchi; Tsugumichi Sato; Kiyoshi Kubota; Takumi Kishimoto
Journal:  Jpn J Clin Oncol       Date:  2010-08-26       Impact factor: 3.019

Review 6.  Morphologic and functional imaging of malignant pleural mesothelioma.

Authors:  Masaki Yamamuro; Victor H Gerbaudo; Ritu R Gill; Francine L Jacobson; David J Sugarbaker; Hiroto Hatabu
Journal:  Eur J Radiol       Date:  2007-10-22       Impact factor: 3.528

7.  Measurement of mesothelioma on thoracic CT scans: a comparison of manual and computer-assisted techniques.

Authors:  Samuel G Armato; Geoffrey R Oxnard; Heber MacMahon; Nicholas J Vogelzang; Hedy L Kindler; Masha Kocherginsky; Adam Starkey
Journal:  Med Phys       Date:  2004-05       Impact factor: 4.071

Review 8.  Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET.

Authors:  Zhen J Wang; Gautham P Reddy; Michael B Gotway; Charles B Higgins; David M Jablons; Mohan Ramaswamy; Randall A Hawkins; W Richard Webb
Journal:  Radiographics       Date:  2004 Jan-Feb       Impact factor: 5.333

Review 9.  MR imaging of benign and malignant pleural disease.

Authors:  Ritu R Gill; Victor H Gerbaudo; Francine L Jacobson; Beatrice Trotman-Dickenson; Shin Matsuoka; Andetta Hunsaker; David J Sugarbaker; Hiroto Hatabu
Journal:  Magn Reson Imaging Clin N Am       Date:  2008-05       Impact factor: 2.266

10.  Metabolic significance of the pattern, intensity and kinetics of 18F-FDG uptake in malignant pleural mesothelioma.

Authors:  V H Gerbaudo; S Britz-Cunningham; D J Sugarbaker; S T Treves
Journal:  Thorax       Date:  2003-12       Impact factor: 9.139
View more
  4 in total

1.  Staging in the era of international databases: documented improvements with remaining challenges.

Authors:  Robert B Cameron
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

Review 2.  Progress in the Management of Malignant Pleural Mesothelioma in 2017.

Authors:  Amanda J McCambridge; Andrea Napolitano; Aaron S Mansfield; Dean A Fennell; Yoshitaka Sekido; Anna K Nowak; Thanyanan Reungwetwattana; Weimin Mao; Harvey I Pass; Michele Carbone; Haining Yang; Tobias Peikert
Journal:  J Thorac Oncol       Date:  2018-03-08       Impact factor: 15.609

3.  Implementing CT tumor volume and CT pleural thickness into future staging systems for malignant pleural mesothelioma.

Authors:  Olivia Lauk; Miriam Patella; Thomas Neuer; Bianca Battilana; Thomas Frauenfelder; Thi Dan Linh Nguyen-Kim; Walter Weder; Claudio Caviezel; Sven Hillinger; Ilhan Inci; Isabelle Opitz
Journal:  Cancer Imaging       Date:  2021-08-03       Impact factor: 3.909

4.  Sarcopenia, Precardial Adipose Tissue and High Tumor Volume as Outcome Predictors in Surgically Treated Pleural Mesothelioma.

Authors:  Oliver Guido Verhoek; Lisa Jungblut; Olivia Lauk; Christian Blüthgen; Isabelle Opitz; Thomas Frauenfelder; Katharina Martini
Journal:  Diagnostics (Basel)       Date:  2022-01-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.